State of the Life Sciences Industry - Fourth Quarter Review

Report Code: HLC314B

Publish Date: Jan 2026

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.
  • The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.
  • The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.

Quarterly Research Review Scope

This quarterly research review provides insights into pharmaceuticals, biopharmaceuticals, medical devices, cell biology and the healthcare sector. This report summarizes the life sciences landscape, highlighting key market trends, emerging opportunities and recent regulatory updates. It tracks sustainability trends through data visualizations that display key metrics, including market size and investment flows. It also provides customized research solutions, including syndicated research, specific market research for particular challenges and data reports for quantitative analysis.

The list of reports that are published in this quarter are:

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: State of the Life Sciences Industry - Fourth Quarter Review181Free
Chapter- 1: Industry Lens on Transformation and Growth3Free
Chapter- 2: Medical Devices and Surgical - Quarterly Review12Free
Chapter- 3: Executive Summary of MDS039B - Contract Manufacturing of Medical Devices5Free
Chapter- 4: Executive Summary of MDS043B - Bioprocess Filtration: Global Markets5Free
Chapter- 5: Executive Summary of MDS111A - Smart Orthopedic Implants: Global Markets5Free
Chapter- 6: Cell Biology - Quarterly Review22Free
Chapter- 7: Executive Summary of BIO011H Separation Systems for Commercial Biotechnology5Free
Chapter- 8: Executive Summary of BIO022J - Botanical and Plant-derived Drugs: Global Markets5Free
Chapter- 9: Executive Summary of BIO048E - Biological Therapies for Cancer: Global Markets5Free
Chapter- 10: Executive Summary of BIO159B -Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing5Free
Chapter- 11: Executive Summary of BIO160B - Cell Therapy Processing: Global Markets and Technologies 5Free
Chapter- 12: Executive Summary of BIO165B - Protein Expression: Global Markets4Free
Chapter- 13: Executive Summary of BIO274A - Fusion Proteins: Global Market 4Free
Chapter- 14: Pharmaceuticals - Quarterly Review23Free
Chapter- 15: Executive Summary of PHM208B - Brain Tumor Therapeutics: Global Markets to 20305Free
Chapter- 16: Executive Summary of PHM165B Advanced Drug Delivery Systems - Focus on Routes of Administration :Global Markets and Technologies6Free
Chapter- 17: Executive Summary of PHM249B - Immunotherapy Drugs: Global Markets5Free
Chapter- 18: Executive Summary of PHM285A - Global Artificial Intelligence (AI) in Clinical Trials Market6Free
Chapter- 19: Executive Summary of PHM286A - Global Oncology Biosimilars Market6Free
Chapter- 20: Executive Summary of PHM289A - Global GLP-1 Analogues Market6Free
Chapter- 21: Healthcare Maintenance - Quarterly Review16Free
Chapter- 22: Executive Summary of HLC311A - Global Healthcare Predictive Analytics Markets4Free
Chapter- 23: Executive Summary of HLC162D - Mobile Health (mHealth) Technologies and Global Markets5Free
Chapter- 24: Executive Summary of HLC019K - Global Markets for Catheters7Free
Chapter- 25: Executive Summary of HLC313A - Global Gene Fusion Testing Market 4Free
Chapter- 26: Upcoming Reports3Free

Related Reports

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO136B

The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

Published - Mar 2025 | Publisher - BCC Publishing | Code - BIO162C

The global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.

Biosimilars: Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - BIO090E

The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO170B

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 26

  • Table 1: List of Life Sciences Reports Published Quarter IV 2025
  • Table 2: Key Moves and Milestones of the Medical Devices and Surgical Category, 2024 - 2025
  • Table 3: Global Market for Contract Manufacturing of Medical Devices, by Region, Through 2030
  • Table 4: Global Market for Bioprocess Filtration, by Region, Through 2030
  • Table 5: Global Market for Smart Orthopedic Implants, by Region, Through 2030
  • Table 6: Key Moves and Milestones of Cell Biology Category Reports, 2024 - 2025
  • Table 7: Global Market for Bioseparation Systems, by Region, Through 2030
  • Table 8: Global Market for Botanical and Plant-Derived Drugs, by Region, Through 2030
  • Table 9: Global Market for Biological Therapies for Cancer, by Product Type, Through 2030
  • Table 10: Global Market for Genetic Modification Therapies, by Region, Through 2030
  • Table 11: Global Market for Cell Therapy Processing, by Region, Through 2030
Sample Report

Recent Reports

Global Sleep Software Market

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC315A

The global market for sleep software was valued at $1.1 billion in 2025 and is projected to reach $1.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2025 to 2030.

State of the Life Sciences Industry - Fourth Quarter Review

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC314B

State of the Life Sciences Industry Market Report delivers insights on biotech, pharma, medical devices, innovation trends, and global market outlook.

Sleep Aids: Technologies and Global Markets

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC081F

The global market for sleep aid technologies is estimated to grow from $103.5 billion in 2025 to reach $136 billion by 2030, at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC029G

The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.

Global Gene Fusion Testing Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - HLC313A

This report provides detailed information on the global gene fusion testing market. It highlights current and future market trends, as well as a comprehensive competitive landscape. The report analyzes market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates (CAGRs) through 2030.

Top Trending Reports

Global GLP-1 Analogues Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - PHM289A

This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Data Center Networking Technologies: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - IFT103C

The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.

Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing

Published - Dec 2025 | Publisher - BCC Publishing | Code - BIO159B

The global market for genetic modification therapies is estimated to grow from $14.8 billion in 2025 to reach $32.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.8% from 2025 through 2030.

Protein Expression: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO165B

The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.

Botanical and Plant-derived Drugs: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - BIO022J

The global market for botanical and plant-derived drugs is expected to grow from $38.7 billion in 2025 and is projected to reach $58.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2025 to 2030.

Published - Oct-2025| Analyst - BCC Publishing| Code - HLC314A

Report Highlights

  • The global market for vision care is expected to grow from $75.1 billion in 2025 and is projected to reach $98 billion by the end of 2030, at a CAGR of 5.5% during the forecast period of 2025 to 2030.
  • The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable or slightly decline to $7.69 billion by the end of 2030, at a CAGR of -0.04% during the forecast period of 2025 to 2030.
  • The global market for anti-Parkinson’s drugs is projected to grow from $6.1 billion in 2025 to reach $9.2 billion by the end of 2030, at a CAGR of 8.6% from 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
State of the Life Sciences Industry - Fourth Quarter Review
Sample Report
AI Sentiment